
HCA · NYSE
HCA Healthcare operates hospitals and related healthcare facilities, providing inpatient, outpatient, emergency and other medical services. It makes money primarily by delivering care that is reimbursed by commercial insurers, government programs and patients, although the supplied evidence does not provide a segment contribution breakdown. Its customers are patients and the insurers or public programs that fund their treatment. HCA generated $75.6 billion of revenue and $6.8 billion of net income in fiscal 2025, up from $70.6 billion and $5.8 billion, respectively, in fiscal 2024. The evidence does not state its current facility count or employee scale.
HCA fell $17.46, or 4.18%, over the stated week, from $418.19 to $400.73. The decline was concentrated in the first two sessions, with the stock dropping to $395.79 by July 30, before recovering to $402.59 and then $406.61. It gave back that rebound on August 4, falling 1.45% to finish at $400.73. The supplied evidence contains no dated company-specific operating announcement explaining the move. Instead, it shows a backdrop of analyst caution, including lower targets from Morgan Stanley, Barclays, Mizuho and Oppenheimer. No broader market or sector performance data was supplied, so the remaining trading pressure cannot be attributed more specifically.